Clinical Trial Update: Gut Microbiota, PGx and INSTIs Response

View source ↗

Summary

Completed clinical trial evaluating how gut microbiota and pharmacogenomics influence response to integrase inhibitors in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: HIV Infections | Status: COMPLETED